A Billion Base Pairs, Times Two

Both the public Human Genome Project and the private Celera Genomics-sponsored effort announced within a month of each other that they have sequenced a billion base pairs--about a third of human's total genetic code. Despite those twin landmarks, it's still difficult to say which project is ahead of the other in the quest to finish a "rough draft," or 90 percent completed copy, by spring 2000. This handicappers' confusion (in a competition both teams have said is not a race1) can be attributed

Written byPaul Smaglik
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Both the public Human Genome Project and the private Celera Genomics-sponsored effort announced within a month of each other that they have sequenced a billion base pairs--about a third of human's total genetic code. Despite those twin landmarks, it's still difficult to say which project is ahead of the other in the quest to finish a "rough draft," or 90 percent completed copy, by spring 2000.

This handicappers' confusion (in a competition both teams have said is not a race1) can be attributed to the different sequencing strategies each effort employs. Publicly funded sequencers are putting finished clones on a map as they go, while the Rockville, Md.-based Celera is first sequencing each into different-size fragments, then matching overlapped areas against each other to form a coherent picture--sort of a biological jigsaw puzzle of unprecedented scope.

Celera first announced its achievement in an Oct. 20 news release; the Human Genome ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series